Regeneron founder, chair and CEO Leonard Schleifer joins 'Squawk Box' to discuss the impact of President Trump's tariff policies on biotech and pharmaceuticals, his thoughts on HHS Secretary RFK Jr., ...

CEO Leonard Schleifer highlighted 10% revenue growth in Q4 2024, attributed to strong performance from Dupixent, Libtayo, and ...

On a call with analysts, Chief Executive and co-Founder Leonard Schleifer said the U.S. Food and Drug Administration has requested more data from trials of Dupixent as a treatment for adults with ...

and relentlessly pursuing cutting-edge science," CEO Leonard Schleifer said. However, Eylea marketed with Bayer (OTCPK:BAYZF) brought $2.3B in net sales with a ~1% YoY drop as its U.S. net product ...

The panel featured Gilead CEO John Milligan, Pfizer CEO Ian Read, incoming Eli Lilly CEO David Ricks, Astellas Americas President Jim Robinson, and Regeneron CEO Leonard Schleifer. After some ...